(Q43950414)

English

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

0 references

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

Ulf de Faire

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

object named as

Björn Dahlöf

0 references

Ole Lederballe-Pedersen

11

object named as

Ole Lederballe-Pedersen

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sverre E. Kjeldsen

9

object named as

Sverre E Kjeldsen

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Richard B Devereux

4

object named as

Richard B Devereux

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

14

object named as

Suzanne Oparil

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Lars H Lindholm

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hans Ibsen

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Gareth Beevers

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Frej Fyhrquist

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Stevo Julius

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Krister Kristiansson

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Markku S Nieminen

12

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Per Omvik

13

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hans Wedel

15

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Peter Aurup

16

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jonathan Edelman

17

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Steven Snapinn

18

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

LIFE Study Group

19

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

359

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

9311

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1004-1010

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

randomized experiment

0 references

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

An updated coronary risk profile. A statement for health professionals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of diabetes on cardiac structure and function: the strong heart study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The renin-angiotensin-aldosterone system: a specific target for hypertension management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908090-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(02)08090-X

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43950414&oldid=2104595685"